We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CYH Agreed to Sell 4 Arkansas Hospitals for $112M to Reduce Debt
Read MoreHide Full Article
Key Takeaways
CYH will sell four Arkansas hospitals and related outpatient operations to Freeman Health for about $112M.
Community Health Systems is pursuing asset sales to focus on profitable resources and reduce its debt load.
CYH reported $10.4B in long-term debt and a net debt-to-EBITDA ratio of 7.26, above the industry average.
Community Health Systems, Inc. (CYH - Free Report) recently announced a definitive agreement to sell four Arkansas hospitals and related outpatient operations to Freeman Health System. The sale consideration is about $112 million in cash, subject to standard adjustments for net working capital and finance leases. The move is part of the company’s ongoing programmatic divestiture strategy, under which it is selling hospitals and non-hospital businesses to focus on more profitable resources.
Under the agreement, CYH will sell substantially all assets of the 128-bed Northwest Medical Center – Bentonville in Bentonville, the 222-bed Northwest Medical Center – Springdale in Springdale, the 64-bed Northwest Medical Center – Willow Creek Women’s Hospital in Johnson, and the 73-bed Siloam Springs Regional Hospital in Siloam Springs. The transaction is expected to close in the second quarter of 2026, subject to regulatory approvals and customary closing conditions.
Franklin, TN-based Community Health Systems continues to operate under a high debt burden. At the end of the fourth quarter, the company reported cash and cash equivalents of $260 million and long-term debt of $10.4 billion. Its net debt-to-EBITDA ratio stands at 7.26, significantly higher than the industry average of 3.36, reflecting its heavy reliance on debt.
Earlier, CYH divested eight facilities in 2023 and two hospitals in 2024. It sold several assets in 2025, including a $260 million deal with AdventHealth and three Pennsylvania hospitals. In January 2026, it agreed to divest its 180-bed Crestwood Medical Center in Huntsville. Management expects the latest divestiture, along with several previous asset sales, to help reduce its debt burden. The proceeds are likely to generate meaningful interest savings and support long-term improvement in profit margins.
CYH’s Price Performance
Community Health’s shares have gained about 16% over the past year, underperforming the industry’s growth of 42.8%.
Image Source: Zacks Investment Research
CYH’s Zacks Rank & Other Key Picks
CYH stock currently carries a Zacks Rank #2 (Buy).
The Zacks Consensus Estimate for BrightSpring Health's current-year earnings is pegged at $1.56 per share, which moved up by 16 cents over the past 30 days, indicating 56% year-over-year growth. The consensus estimate for current-year revenues is pinned at $14.8 billion, indicating 14.9% year-over-year growth. BTSG beat earnings estimates in three of the trailing four quarters and missed once, delivering an average surprise of 40.4%.
The Zacks Consensus Estimate for Catalyst Pharmaceuticals’ current-year earnings is pinned at $2.82 per share, which moved 29 cents up over the past seven days. CPRX beat earnings estimates in each of the trailing four quarters, with an average surprise of 35.2%. The consensus estimate for current-year revenues is pegged at $630.3 million, suggesting 7% year-over-year growth.
The Zacks Consensus Estimates for Globus Medical's current-year earnings are pegged at $4.28 per share, implying a 7.5% increase from the year-ago reported figure. GMED’s bottom line moved up 27 cents over the past seven days. The consensus mark for current-year revenues is pinned at $3.2 billion, indicating 8% year-over-year growth.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
CYH Agreed to Sell 4 Arkansas Hospitals for $112M to Reduce Debt
Key Takeaways
Community Health Systems, Inc. (CYH - Free Report) recently announced a definitive agreement to sell four Arkansas hospitals and related outpatient operations to Freeman Health System. The sale consideration is about $112 million in cash, subject to standard adjustments for net working capital and finance leases. The move is part of the company’s ongoing programmatic divestiture strategy, under which it is selling hospitals and non-hospital businesses to focus on more profitable resources.
Under the agreement, CYH will sell substantially all assets of the 128-bed Northwest Medical Center – Bentonville in Bentonville, the 222-bed Northwest Medical Center – Springdale in Springdale, the 64-bed Northwest Medical Center – Willow Creek Women’s Hospital in Johnson, and the 73-bed Siloam Springs Regional Hospital in Siloam Springs. The transaction is expected to close in the second quarter of 2026, subject to regulatory approvals and customary closing conditions.
Franklin, TN-based Community Health Systems continues to operate under a high debt burden. At the end of the fourth quarter, the company reported cash and cash equivalents of $260 million and long-term debt of $10.4 billion. Its net debt-to-EBITDA ratio stands at 7.26, significantly higher than the industry average of 3.36, reflecting its heavy reliance on debt.
Earlier, CYH divested eight facilities in 2023 and two hospitals in 2024. It sold several assets in 2025, including a $260 million deal with AdventHealth and three Pennsylvania hospitals. In January 2026, it agreed to divest its 180-bed Crestwood Medical Center in Huntsville. Management expects the latest divestiture, along with several previous asset sales, to help reduce its debt burden. The proceeds are likely to generate meaningful interest savings and support long-term improvement in profit margins.
CYH’s Price Performance
Community Health’s shares have gained about 16% over the past year, underperforming the industry’s growth of 42.8%.
Image Source: Zacks Investment Research
CYH’s Zacks Rank & Other Key Picks
CYH stock currently carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks in the broader Medical sector are BrightSpring Health Services, Inc. (BTSG - Free Report) , Catalyst Pharmaceuticals, Inc. (CPRX - Free Report) and Globus Medical, Inc. (GMED - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for BrightSpring Health's current-year earnings is pegged at $1.56 per share, which moved up by 16 cents over the past 30 days, indicating 56% year-over-year growth. The consensus estimate for current-year revenues is pinned at $14.8 billion, indicating 14.9% year-over-year growth. BTSG beat earnings estimates in three of the trailing four quarters and missed once, delivering an average surprise of 40.4%.
The Zacks Consensus Estimate for Catalyst Pharmaceuticals’ current-year earnings is pinned at $2.82 per share, which moved 29 cents up over the past seven days. CPRX beat earnings estimates in each of the trailing four quarters, with an average surprise of 35.2%. The consensus estimate for current-year revenues is pegged at $630.3 million, suggesting 7% year-over-year growth.
The Zacks Consensus Estimates for Globus Medical's current-year earnings are pegged at $4.28 per share, implying a 7.5% increase from the year-ago reported figure. GMED’s bottom line moved up 27 cents over the past seven days. The consensus mark for current-year revenues is pinned at $3.2 billion, indicating 8% year-over-year growth.